-
Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases
Mar 10, 2025, 14:00 PM -
Prediction of Myasthenia Gravis (MG) Crisis Events by a Machine Learning (ML) Algorithm
Mar 10, 2025, 14:00 PM -
Unlocking AI's Potential in Pricing and Reimbursement: Insights Across Global Healthcare Archetypes
Mar 10, 2025, 14:00 PM -
Improving Design Choices in Delphi Studies for Clinical Consensus Recommendations: Results of a Pilot Approach to Rapid, High-Quality Engagement
Mar 10, 2025, 14:00 PM -
Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database
Mar 10, 2025, 14:00 PM -
Increasing Clinical Trial Participation in Native Hawaiian, Pacific Islander, and Asian Communities
Mar 10, 2025, 14:00 PM -
Economic and Environmental Impact of Decentralized Cancer Care (DCC) in Oncology: An Innovative Experience in the French Alps
Mar 10, 2025, 14:00 PM -
Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Follitropin Delta versus Follitropin Alfa in Controlled Ovarian Stimulation for IVF/ICSI Cycles in China
Mar 10, 2025, 14:00 PM -
Large-Language Models to Complement and Augment Literature Review: Hi! How Can I Help You?
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life in Individuals with Diagnosed Depression, Self-Reported Depression, and Non-Depressed: A Multi-Center Cross-Sectional Study
Mar 10, 2025, 14:00 PM -
Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Polygenic Risk Score-Guided Breast Cancer Screening Using a Discrete Event Simulation Model
Mar 10, 2025, 14:00 PM -
Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape
Mar 10, 2025, 14:00 PM -
Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access
Mar 10, 2025, 14:00 PM -
Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults
Mar 10, 2025, 14:00 PM -
Impact of Information Technology Enhancement for Human Papillomavirus Vaccination: Time and Cost Savings
Mar 10, 2025, 14:00 PM -
Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study
Mar 10, 2025, 14:00 PM -
Unravelling the Diagnostic Delays and Disease Burden Associated with Endometriosis - A Targeted Literature Review
Mar 10, 2025, 14:00 PM
